Literature DB >> 11786409

Lymphoid follicles are generated in high-grade cervical dysplasia and have differing characteristics depending on HIV status.

Akiko Kobayashi1, Teresa Darragh, Brian Herndier, Kathryn Anastos, Howard Minkoff, Mardge Cohen, Mary Young, Alexandra Levine, Linda Ahdieh Grant, William Hyun, Vivian Weinberg, Ruth Greenblatt, Karen Smith-McCune.   

Abstract

The exact role of the mucosal immune response in the pathogenesis of human papillomavirus (HPV)-related premalignant and malignant diseases of the genital tract is poorly understood. We used immunohistochemical analysis to characterize immune cells in normal cervix (N = 21), HIV-negative high-grade dysplasia (N = 21), and HIV-positive high-grade dysplasia (N = 30). Classical germinal centers were present in 4.7% of normal cervix, 33% of high-grade lesions from HIV-negative women, and 3.3% of high-grade lesions from HIV-positive women (P = 0.003). HPV16 E7 antigen was detected in a subset of germinal centers, indicating that the secondary immune response was directed in part against HPV. Lymphoid follicles were present in 9.5% of normal cervix, 57% of HIV-negative high-grade dysplasia, and 50% of HIV-positive high-grade dysplasia (P = 0.001 normal versus high-grade). A novel type of lymphoid aggregate, consisting predominantly of CD8(+) T cells, was detected in 4.8% of normal cervix, 0% of HIV-negative high-grade dysplasia, and 40% of HIV-positive high-grade dysplasia (P < 0.001). The recurrence rate of high-grade dysplasia within one year was significantly higher in women with such CD8(+) T cell-dominant aggregates (P = 0.02). In summary, the types of lymphoid follicle in lesions from HIV-positive women were significantly different from those from HIV-negative women, and these differences are associated with the worse clinical outcome in HIV-positive women.

Entities:  

Mesh:

Year:  2002        PMID: 11786409      PMCID: PMC1867118          DOI: 10.1016/s0002-9440(10)64359-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma.

Authors:  T Anttila; P Saikku; P Koskela; A Bloigu; J Dillner; I Ikäheimo; E Jellum; M Lehtinen; P Lenner; T Hakulinen; A Närvänen; E Pukkala; S Thoresen; L Youngman; J Paavonen
Journal:  JAMA       Date:  2001-01-03       Impact factor: 56.272

2.  Mucosal immunity in the female reproductive tract: correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation.

Authors:  W H Kutteh; Z Moldoveanu; J Mestecky
Journal:  AIDS Res Hum Retroviruses       Date:  1998-04       Impact factor: 2.205

3.  Do HPV-negative cervical carcinomas exist?

Authors:  J M Walboomers; C J Meijer
Journal:  J Pathol       Date:  1997-03       Impact factor: 7.996

4.  Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response.

Authors:  Y Fang; C Xu; Y X Fu; V M Holers; H Molina
Journal:  J Immunol       Date:  1998-06-01       Impact factor: 5.422

5.  T lymphocytes infiltrating advanced grades of cervical neoplasia. CD8-positive cells are recruited to invasion.

Authors:  R P Edwards; K Kuykendall; P Crowley-Nowick; E E Partridge; H M Shingleton; J Mestecky
Journal:  Cancer       Date:  1995-10-15       Impact factor: 6.860

6.  Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection.

Authors:  J Andersson; H Behbahani; J Lieberman; E Connick; A Landay; B Patterson; A Sönnerborg; K Loré; S Uccini; T E Fehniger
Journal:  AIDS       Date:  1999-07-30       Impact factor: 4.177

7.  Lower genital tract infections among HIV-infected and high-risk uninfected women: findings of the Women's Interagency HIV Study (WIHS).

Authors:  R M Greenblatt; P Bacchetti; S Barkan; M Augenbraun; S Silver; R Delapenha; P Garcia; U Mathur; P Miotti; D Burns
Journal:  Sex Transm Dis       Date:  1999-03       Impact factor: 2.830

8.  Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: a prognostic study.

Authors:  P B Bethwaite; L J Holloway; A Thornton; B Delahunt
Journal:  Pathology       Date:  1996-11       Impact factor: 5.306

9.  From the Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

Authors: 
Journal:  JAMA       Date:  1993-02-10       Impact factor: 56.272

10.  Chlamydiae, cervicitis, and abnormal Papanicolaou smears.

Authors:  M C Carr; L Hanna; E Jawetz
Journal:  Obstet Gynecol       Date:  1979-01       Impact factor: 7.661

View more
  14 in total

1.  B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas.

Authors:  Nesrine I Affara; Brian Ruffell; Terry R Medler; Andrew J Gunderson; Magnus Johansson; Sophia Bornstein; Emily Bergsland; Martin Steinhoff; Yijin Li; Qian Gong; Yan Ma; Jane F Wiesen; Melissa H Wong; Molly Kulesz-Martin; Bryan Irving; Lisa M Coussens
Journal:  Cancer Cell       Date:  2014-06-05       Impact factor: 31.743

Review 2.  Tissue-resident memory T cells.

Authors:  Jason M Schenkel; David Masopust
Journal:  Immunity       Date:  2014-12-06       Impact factor: 31.745

3.  Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.

Authors:  Sanjana Balachandra; Samuel B Kusin; Rebecca Lee; James-Michael Blackwell; Jasmin A Tiro; Lindsay G Cowell; Cheng-Ming Chiang; Shwu-Yuan Wu; Sanskriti Varma; Erika L Rivera; Helen G Mayo; Lianghao Ding; Baran D Sumer; Jayanthi S Lea; Aditya Bagrodia; Linda M Farkas; Richard Wang; Carole Fakhry; Kristina R Dahlstrom; Erich M Sturgis; Andrew T Day
Journal:  Cancer       Date:  2020-12-03       Impact factor: 6.860

Review 4.  Gynecologic issues in the HIV-infected woman.

Authors:  Helen E Cejtin
Journal:  Infect Dis Clin North Am       Date:  2008-12       Impact factor: 5.982

Review 5.  B cells and their mediators as targets for therapy in solid tumors.

Authors:  Andrew J Gunderson; Lisa M Coussens
Journal:  Exp Cell Res       Date:  2013-03-13       Impact factor: 3.905

Review 6.  Cell-mediated immunity to HIV in the female reproductive tract.

Authors:  Barbara L Shacklett
Journal:  J Reprod Immunol       Date:  2009-10-25       Impact factor: 4.054

7.  Th17 Cells Are Preferentially Infected Very Early after Vaginal Transmission of SIV in Macaques.

Authors:  Daniel J Stieh; Edgar Matias; Huanbin Xu; Angela J Fought; James L Blanchard; Preston A Marx; Ronald S Veazey; Thomas J Hope
Journal:  Cell Host Microbe       Date:  2016-04-13       Impact factor: 21.023

Review 8.  The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions-Evidence for Estrogen as an Immunomodulator.

Authors:  Jayshree R S
Journal:  Front Cell Infect Microbiol       Date:  2021-04-30       Impact factor: 5.293

9.  Detection of intraepithelial and stromal Langerin and CCR5 positive cells in the human endometrium: potential targets for HIV infection.

Authors:  Tove Kaldensjö; Pernilla Petersson; Anna Tolf; Gareth Morgan; Kristina Broliden; Taha Hirbod
Journal:  PLoS One       Date:  2011-06-29       Impact factor: 3.240

10.  Koilocytes indicate a role for human papilloma virus in breast cancer.

Authors:  J S Lawson; W K Glenn; B Heng; Y Ye; B Tran; L Lutze-Mann; N J Whitaker
Journal:  Br J Cancer       Date:  2009-09-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.